Focus on Bipolar Disorder: 6 New Studies

Treatment failure risk is high, new biomarker of conversion from major depressive disorder, depression stifles creativity, and other recent findings are summarized here.

Related Videos
Related Content

Exploring the Future of Mental Health

May 19th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

NDA Approved for Long-Acting Injectable for Schizophrenia and Bipolar I

April 28th 2023

Four Myths About Lamotrigine

August 3rd 2021

Role of Lithium in 2023 in Bipolar I Mania and Depression

April 14th 2023

The Week in Review: March 27-31

April 1st 2023

Exploring the Future of Mental Health

May 19th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

NDA Approved for Long-Acting Injectable for Schizophrenia and Bipolar I

April 28th 2023

Four Myths About Lamotrigine

August 3rd 2021

Role of Lithium in 2023 in Bipolar I Mania and Depression

April 14th 2023

The Week in Review: March 27-31

April 1st 2023

Exploring the Future of Mental Health

May 19th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

NDA Approved for Long-Acting Injectable for Schizophrenia and Bipolar I

April 28th 2023

Four Myths About Lamotrigine

August 3rd 2021

Role of Lithium in 2023 in Bipolar I Mania and Depression

April 14th 2023

The Week in Review: March 27-31

April 1st 2023
© 2023 MJH Life Sciences

All rights reserved.